About 316 results
Open links in new tab
  1. Fierce Pharma Biopharma News & Insights

    Oct 2, 2025 · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.

  2. Trump admin rolls out EU trade deal with 15% pharma tariff rate

    Aug 21, 2025 · The terms of the deal likely provide some relief for the EU’s pharmaceutical industry, which now appears to be immune to higher sectoral tariffs that the Trump administration aims to …

  3. Marketing - Fierce Pharma

    Nov 25, 2025 · Updates on DTC ads and DTP programs, as well as special reports, event coverage and news bulletins on GLP-1s were among 2025's most-read stories.

  4. Trump's pharmaceutical tariffs materialize at last in new US-EU trade ...

    Jul 29, 2025 · At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union.

  5. Manufacturing - Fierce Pharma

    Dec 17, 2025 · Connect The Team Advertise Marketing Kit Let's Talk Join Us Newsletters Resources RSS Feeds Our Brands Fierce Biotech Fierce Healthcare Fierce Pharma Our Events Life Sciences …

  6. UK pharma drug price talks break down as industry fails to lower ...

    Aug 22, 2025 · While the terms of the current VPAG period were reached in 2023, rising health demands and the introduction of newer drugs have put more pressure on the pharma industry to …

  7. Drugmakers, trade groups and others hit back on tariff threat

    May 29, 2025 · Governments, trade groups and drugmakers have struck back against potential pharma tariffs in comments on a U.S. import investigation.

  8. Of 22 top drugmakers, 21 showed revenue increases in Q4

    Feb 24, 2025 · Revenues in the biopharma industry continued to boom in the fourth quarter of last year. Of 22 top companies, only one had a year-over-year decline.

  9. 2024 approvals: Biopharma delivered 55 new drugs, biologics

    Jan 2, 2025 · Most of the drugmakers that scored multiple approvals in 2024 were the usual Big Pharma suspects—Eli Lilly, Merck, Pfizer and Roche. But there was an under-the-radar company that also …

  10. Podcasts - Fierce Pharma

    We’ll analyze the week’s biggest business news – from mergers and marketing to drug R&D and device development. Available every Friday morning.